Most Prescribed Drugs in England — NHS Prescribing Data — Page 25
Showing 721-750 of 2,661
| # | Drug | Category | Items | NHS Cost | Practices |
|---|---|---|---|---|---|
| 721 | Aluminium chloride | Skin | 45.5K | £285.0K | 5,617 |
| 722 | Dressings | 45.4K | £65.7K | 1,717 | |
| 723 | Apraclonidine | Eye | 45.0K | £3.4M | 3,569 |
| 724 | Dimeticone (Barrier) | Skin | 44.8K | £220.0K | 3,044 |
| 725 | Incontinence Appliances | 44.5K | £628.0K | 3,277 | |
| 726 | Co-cyprindiol (Cyprote acetate/ethinylestradiol) | Skin | 44.4K | £438.2K | 5,123 |
| 727 | Ketorolac trometamol | Eye | 44.0K | £231.5K | 4,745 |
| 728 | Tafluprost and timolol | Eye | 43.9K | £832.9K | 2,286 |
| 729 | Ciprofloxacin | Eye | 43.4K | £222.8K | 5,455 |
| 730 | Tars | Skin | 43.3K | £818.0K | 5,172 |
| 731 | Co-amilozide (Amiloride hydrochloride/hydrochlorothiazide) | Cardiovascular System | 43.3K | £758.5K | 2,645 |
| 732 | Mometasone furoate/olopatadine hydrochloride | Ear, Nose and Oropharynx | 43.2K | £591.6K | 3,978 |
| 733 | Phenazone/lidocaine | Ear, Nose and Oropharynx | 42.9K | £365.9K | 4,191 |
| 734 | Oxazepam | Central Nervous System | 42.6K | £195.7K | 2,001 |
| 735 | Emulsifying wax | Skin | 42.5K | £204.4K | 3,486 |
| 736 | Almotriptan | Central Nervous System | 42.3K | £877.6K | 3,415 |
| 737 | Ready to serve infant formula, high energy (0913104) | Nutrition and Blood | 42.3K | £8.5M | 3,828 |
| 738 | Stoma Appliances | 42.3K | £4.4M | 2,265 | |
| 739 | Mebeverine hydrochloride compound preparations | Gastro-Intestinal System | 42.3K | £1.9M | 3,737 |
| 740 | Acrivastine | Respiratory System | 42.2K | £909.6K | 3,428 |
| 741 | Entacapone | Central Nervous System | 42.1K | £921.6K | 2,759 |
| 742 | Powder 1.5 kcal/ml smoothie plant based (0913011) | Nutrition and Blood | 42.0K | £1.4M | 3,896 |
| 743 | Appliances | 41.9K | £889.9K | 4,879 | |
| 744 | Meptazinol hydrochloride | Central Nervous System | 41.7K | £632.8K | 1,262 |
| 745 | Stoma Appliances | 41.4K | £1.2M | 2,690 | |
| 746 | Inclisiran | Cardiovascular System | 41.2K | £2.0M | 3,273 |
| 747 | Dexamethasone sodium metasulphobenzoate | Ear, Nose and Oropharynx | 41.1K | £307.5K | 5,527 |
| 748 | Captopril | Cardiovascular System | 40.8K | £2.2M | 2,819 |
| 749 | Methotrexate | Malignant Disease and Immunosuppression | 40.7K | £2.6M | 1,366 |
| 750 | Appliances | 40.7K | £4.8M | 4,677 |